PREVIEW
The enormous morbidity and mortality associated with type II diabetes imposes a heavy burden on society—in terms of both human suffering and economic resources. With the incidence increasing to epidemic proportions among some segments of the population, identifying ways to prevent the disease has become a major public health concern. Drs Mudaliar and Henry discuss the rationale for early identification of at-risk patients, along with nonpharmacologic and pharmacologic approaches to primary intervention.